Prostacyclin prevents nitric oxide-induced megakaryocyte apoptosis

British Journal of Pharmacology

Volumn 145, Issue 3, 2005, Pages 283-292

  Pozner, Roberto Gabriel ^a   Negrotto, Soledad ^a   D'Atri, Lina Paola ^a   Kotler, Mónica Lidia ^b   Lazzari, María Angela ^a   Gomez, Ricardo Martin ^c   Schattner, Mirta ^a  

^a ACADEMIA NACIONAL DE MEDICINA   (Argentina)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^c UNIVERSIDAD NACIONAL DE LA PLATA   (Argentina)

Author keywords

cAMP; Caspase; cGMP; NO; PGI 2

Indexed keywords

1 PROPANAMINE 3 (2 HYDROXY 2 NITROSO 1 PROPYLHYDRAZINE); 4 (3 BUTOXY 4 METHOXYBENZYL) 2 IMIDAZOLIDINONE; 4 AMINO 5 CYCLOPROPYL 2 [1 (2 FLUOROBENZYL) 1H PYRAZOLO[3,4 B]PYRIDIN 3 YL]PYRIMIDINE; 8 (4 CHLOROPHENYLTHIO) CYCLIC AMP; 9 (TETRAHYDRO 2 FURYL)ADENINE; ADENYLATE CYCLASE; BUCLADESINE; CASPASE 3; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; CYCLIC GMP; CYCLIC GMP PHOSPHODIESTERASE; CYCLIC NUCLEOTIDE; GUANYLATE CYCLASE; HYDRAZINE DERIVATIVE; NITRIC OXIDE; PHOSPHODIESTERASE INHIBITOR; PKI 1422; PROSTACYCLIN; UNCLASSIFIED DRUG; ZAPRINAST;

APOPTOSIS; ARTICLE; CELL SURVIVAL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG POTENTIATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; MEGAKARYOCYTE; NEWBORN; PRIORITY JOURNAL;

APOPTOSIS; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; EPOPROSTENOL; HUMANS; MEGAKARYOCYTES; NITRIC OXIDE;

EID: 21244494463     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0706200     Document Type: Article

References (43)

1. AVECILLA, S.T., HATTORI, K., HEISSIG, B., TEJADA, R., LIAO, F., SHIDO, K., JIN, D.K., DIAS, S., ZHANG, F., HARTMAN, T.E., HACKETT, N.R., CRYSTAL, R.G., WITTE, L., HICKLIN, D.J., BOHLEN, P., EATON, D., LYDEN, D., DE SAUVAGE, F. & RAFII, S. (2004). Chemokine-mediated interaction of hematopoietic progenitors with the bone marrow vascular niche is required for thrombopoiesis. Nat. Med., 10, 64-71 (Epub 21 Dec 2003).
2. BATTINELLI, E. & LOSCALZO, J. (2000). Nitric oxide induces apoptosis in megakaryocytic cell lines. Blood, 95, 3451-3459.
3. BATTINELLI, E., WILLOUGHBY, S.R., FOXALL, T., VALERI, C.R. & LOSCALZO, J. (2001). Induction of platelet formation from megakaryocytoid cells by nitric oxide. Proc. Natl. Acad. Sci. U.S.A., 98, 14458-14463.
4. BEST, L.C., MARTIN, T.J., RUSSELL, R.G. & PRESTON, F.E. (1977). Prostacyclin increases cyclic AMP levels and adenylate cyclase activity in platelets. Nature, 267, 850-852.
5. BURSCH, W., TAPER, H.S., SOMER, M.P., MEYER, S., PUTZ, B. & SCHULTE-HERMANN, R. (1989). Histochemical and biochemical studies on the effect of the prostacyclin derivative iloprost on CCl4-induced lipid peroxidation in rat liver and its significance for hepatoprotection. Hepalology, 9, 830-838.
6. CHAE, I.H., PARK, K.W., KIM, H.S. & OH, B.H. (2004). Nitric oxide-induced apoptosis is mediated by Bax/Bcl-2 gene expression, transition of cytochrome c, and activation of caspase-3 in rat vascular smooth muscle cells. Clin. Chim. Acta. 341, 83-91.
7. CHICHE, J.D., SCHLUTSMEYER, S.M., BLOCH, D.B., DE LA MONTE, S.M., ROBERTS JR, J.D., FILIPPOV, G., JANSSENS, S.P., ROSENZWEIG, A. & BLOCH, K.D. (1998). Adenovirus-mediated gene transfer of cGMP-dependent protein kinase increases the sensitivity of cultured vascular smooth muscle cells to the antiproliferative and pro-apoptotic effects of nitric oxide/cGMP. J. Biol. Chem., 273, 34263-34271.
8. COLIGAN, J., KRUIBEEK, A., MARGULIES, D., SHEVACH, E. & STROBER, W. (1994). Morphological and biochemical assays of apoptosis. In: Current Protocols in Immunology, eds. Coligan, J., Kruisbeer, A., Margulies, D., Shevach, E. & Strober, W. pp. 3.17, New York: John Wiley & Sons Inc.
9. CORBIN, J.D., TURKO, I.V., BEASLEY, A. & FRANCIS, S.H. (2000). Phosphorylation of phosphodiesterase-5 by cyclic nucleotide-dependent protein kinase alters its catalytic and allosteric cGMP-binding activities. Eur. J. Biochem., 267, 2760-2767.
10. CUTLER, N.S., GRAVES-DEAL, R., LAFLEUR, B.J., GAO, Z., BOMAN, B.M., WHITEHEAD, R.H., TERRY, E., MORROW, J.D. & COFFEY, R.J. (2003). Stromal production of prostacyclin confers an antiapoptotic effect to colonic epithelial cells. Cancer Res., 63, 1748-1751.
11. DE BOTTON, S., SABRI, S., DAUGAS, E., ZERMATI, Y., GUIDOTTI, J.E., HERMINE, O., KROEMER, G., VAINCHENKER, W. & DEBILI, N. (2002). Platelet formation is the consequence of caspase activation within megakaryocytes. Blood, 100, 1310-1317.
12. DE SAUVAGE, F.J., CARVER-MOORE, K., LUOH, S.M., RYAN, A., DOWD, M., EATON, D.L. & MOORE, M.W. (1996). Physiological regulation of early and late stages of megakaryocytopoiesis by thrombopoietin. J. Exp. Med., 183, 651-656.
13. DIVALD, A., JENEY, A., NAGY, J.O., TIMAR, F. & LAPIS, K. (1990). Modification of the inhibitory effects of CCl4 on phospholipid and protein biosynthesis by prostacyclin. Biochem. Pharmacol., 40, 1477-1483.
14. GRUNBERG, B., NEGRESCU, E. & SIESS, W. (1995). Synergistic phosphorylation of platelet rap1B by SIN-1 and iloprost. Eur. J. Pharmacol., 288, 329-333.
15. HATAE, T., WADA, M., YOKOYAMA, C., SHIMONISHI, M. & TANABE, T. (2001). Prostacyclin-dependent apoptosis mediated by PPAR delta. J. Biol. Chem., 276, 46260-46267.
16. JANG, E.K., AZZAM, J.E., DICKINSON, N.T., DAVIDSON, M.M. & HASLAM, R.J. (2002). Roles for both cyclic GMP and cyclic AMP in the inhibition of collagen-induced platelet aggregation by nitroprusside. Br. J. Haematol., 117, 664-675.
17. JARRY, A., CHARRIER, L., BOU-HANNA, C., DEVILDER, M.C., CRUSSAIRE, V., DENIS, M.G., VALLETTE, G. & LABOISSE, C.L. (2004). Position in cell cycle controls the sensitivity of colon cancer cells to nitric oxide-dependent programmed cell death. Cancer Res., 64, 4227-4234.
18. KAMINSKI, A., GAO, H. & MORGAN, N.G. (2004). Involvement of the cGMP signalling pathway in the regulation of viability in insulin-secreting BRIN-BD11 cells. FEBS Lett., 559, 118-124.
19. KIM, S.J., HWANG, S.O., KIM, I.C. & CHUN, J.S. (2003). Actin cytoskeletal architecture regulates nitric oxide-induced apoptosis, dedifferentiation, and cyclooxygenase-2 expression in articular chondrocytes via mitogen-activated protein kinase and protein kinase C pathways. J. Biol. Chem.. 278, 42448-42456 (Epub 7 Aug 2003).
20. KONTUREK, S.J., BRZOZOWSKI, T., PIASTUCKI, I., DEMBINSKI, A., RADECKI, T., DEMBINSKA-KIEC, A., ZMUDA, A. & GREGORY, H. (1981). Role of mucosal prostaglandins and DNA synthesis in gastric cytoprotection by luminal epidermal growth factor. Gut. 22, 927-932.
21. KROLL, B., KUNZ, S., TU, N. & SCHWARZ, L.R. (1998). Inhibition of transforming growth factor-beta1 and UV light-induced apoptosis by prostanoids in primary cultures of rat hepatocytes. Toxicol. Appl. Pharmacol., 152, 240-250.
22. LOSCALZO, J. (2001). Nitric oxide insufficiency, platelet activation, and arterial thrombosis. Circ. Res., 88, 756-762.
23. LOWETH, A.C., WILLIAMS, G.T., SCARPELLO, J.H. & MORGAN, N.G. (1997). Evidence for the involvement of cGMP and protein kinase G in nitric oxide-induced apoptosis in the pancreatic B-cell line, HIT-T15. FEBS Lett., 400, 285-288.
24. MAURICE, D.H. & HASLAM, R.J. (1990). Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP. Mol. Pharmacol., 37, 671-681.
25. MCCONKEY, D.J. & ORRENIUS, S. (1996). Signal transduction pathways in apoptosis. Stem Cells. 14, 619-631.
26. MEYER ZU VILSENDORF, A., LINK, C., JORNS, A., NAGEL, E. & KOHL, J. (2001). Preconditioning with the prostacyclin analog epoprostenol and cobra venom factor prevents reperfusion injury and hyperacute rejection in discordant liver xenotransplantation. Xenotransplantation, 8, 41-47.
27. MOLINO, M., WOOLKALIS, M.J., PREVOST, N., PRATICO, D., BARNATHAN, E.S., TARABOLETTI, G., HAGGARTY, B.S., HESSELGESSER, J., HORUK, R., HOXIE, J.A. & BRASS, L.F. (2000). CXCR4 on human endothelial cells can serve as both a mediator of biological responses and as a receptor for HIV-2. Biochim. Biophys. Acta. 1500, 227-240.
28. MORO, M.A., RUSSEL, R.J., CELLEK, S., LIZASOAIN, I., SU, Y., DARLEY-USMAR, V.M., RADOMSKI, M.W. & MONCADA, S. (1996). cGMP mediates the vascular and platelet actions of nitric oxide: confirmation using an inhibitor of the soluble guanylyl cyclase. Proc. Natl. Acad. Sci. U.S.A., 93, 1480-1485.
29. POLLMAN, M.J., YAMADA, T., HORIUCHI, M. & GIBBONS, G.H. (1996). Vasoactive substances regulate vascular smooth muscle cell apoptosis. Countervailing influences of nitric oxide and angiotensin II. Circ. Res., 79, 748-756.
30. RABKIN, S.W. & KONG, J.Y. (2000). Nitroprusside induces cardiomyocyte death: interaction with hydrogen peroxide. Am. J. Physiol. Heart Circ. Physiol., 279, H3089-H3100.
31. RADOMSKI, M.W. & MONCADA, S. (1993). The biological and pharmacological role of nitric oxide in platelet function. Adv. Exp. Med. Biol., 344, 251-264.
32. RADOMSKI, M.W., PALMER, R.M. & MONCADA, S. (1987). Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets. Br. J. Pharmacol., 92, 181-187.
33. SANZ, C., BENET, I., RICHARD, C., BADIA, B., ANDREU, E.J., PROSPER, F. & FERNANDEZ-LUNA, J.L. (2001). Antiapoptotic protein Bcl-x(L) is up-regulated during megakaryocytic differentiation of CD34(+) progenitors but is absent from senescent megakaryocytes. Exp. Hematol., 29, 728-735.
34. SASAKI, Y., TAKAHASHI, T., TANAKA, I., NAKAMURA, K., OKUNO, Y., NAKAGAWA, O., NARUMIYA, S. & NAKAO, K. (1997). Expression of prostacyclin receptor in human megakaryocytes. Blood, 90, 1039-1046.
35. SCHATTNER, M., POZNER, R.G., ENGELBERGER, I., GOROSTIZAGA, A., MAUGERI, N., GOMEZ, R., PASQUALINI, A., TORRES, O. & LAZZARI, M.A. (2001). Effect of nitric oxide on megakaryocyte growth induced by thrombopoietin. J. Lab. Clin. Med., 137, 261-269.
36. SCHMITZ, B., RADBRUCH, A., KUMMEL, T., WICKENHAUSER, C., KORB, H., HANSMANN, M.L., THIELE, J. & FISCHER, R. (1994). Magnetic activated cell sorting (MACS) - a new immunomagnetic method for megakaryocytic cell isolation: comparison of different separation techniques. Eur. J. Haematol., 52, 267-275.
37. SCHWARZ, U.R., WALTER, U. & EIGENTHALER, M. (2001). Taming platelets with cyclic nucleotides. Biochem. Pharmacol., 62, 1153-1161.
38. STASCH, J.P., BECKER, E.M., ALONSO-ALIJA, C., APELER, H., DEMBOWSKY, K., FEURER, A., GERZER, R., MINUTH, T., PERZBORN, E., PLEISS, U., SCHRODER, H., SCHROEDER, W., STAHL, E., STEINKE, W., STRAUB, A. & SCHRAMM, M. (2001). NO-independent regulatory site on soluble guanylate cyclase. Nature, 410, 212-215.
39. SUENOBU, N., SHICHIRI, M., IWASHINA, M., MARUMO, F. & HIRATA, Y. (1999). Natriuretic peptides and nitric oxide induce endothelial apoptosis via a cGMP-dependent mechanism. Arterioscler. Thromb. Vasc. Biol., 19, 140-146.
40. VANE, J.R. & BOTTING, R.M. (1995). Pharmacodynamic profile of prostacyclin. Am. J. Cardiol., 75, 3A-10A.
41. VELARDEZ, M.O., POLIANDRI, A.H., CABILLA, J.P., BODO, C.C., MACHIAVELLI, L.I. & DUVILANSKI, B.H. (2004). Long-term treatment of anterior pituitary cells with nitric oxide induces programmed cell death. Endocrinology, 145, 2064-2070 (Epub 30 Dec 2003).
42. WARD, C., WONG, T.H., MURRAY, J., RAHMAN, I., HASLETT, C., CHILVERS, E.R. & ROSSI, A.G. (2000). Induction of human neutrophil apoptosis by nitric oxide donors: evidence for a caspase-dependent, cyclic-GMP-independent, mechanism. Biochem. Pharmacol., 59, 305-314.
43. WU, C.F., BISHOPRIC, N.H. & PRATT, R.E. (1997). Atrial natriuretic peptide induces apoptosis in neonatal rat cardiac myocytes. J. Biol. Chem., 272, 14860-14866.